DYRK1A and NFATC1 were highly expressed in a variety of glioma cell lines, including U87, U251, and T98G cells, compared to normal human astrocytes (NHA) and non‐glioma cell line HEK293 cells (Figure 1E, DYRK1A: 120.10% ± 0.86, *p < 0.01, U87 vs. NHA; 164.00% ± 0.90, *p < 0.001, U251 vs. NHA; 142.40% ± 1.61, *p < 0.001, T98G vs. NHA; 86.52% ± 1.02, *p < 0.01, HEK293 vs. NHA. Here, DYRK1A is linked to central nervous system cancer.